Search
Menu
Home
HTB
2018
July
July 2018
Contents
Editorial
11 July 2018: vol 19 no 12: DTG and preconception – special report
Special reports
Fit for purpose: Antiretroviral treatment optimisation July 2018
Fit for purpose 2018 – PDF
HIV pipeline 2018: full version
Dolutegravir preconception signal: time is up for shoddy surveillance
Conference reports
What to watch: HIV cure-related research at AIDS 2018
AIDS 2018: Programme online and late-breaker highlights announced three weeks before the conference
Antiretrovirals
Bictegravir/FTC/TAF (Biktarvy) approved in Europe
Women's health
Dolutegravir: need to consider all pros and cons before switching in pregnancy
Pregnancy
Why U=U does not apply to breastfeeding
PDFs
11 July 2018: vol 19 no 12
HTB RSS
Early access
RIO study: Dual-bNABs keep viral load undetectable off-ART – plus a potential first case of vaccine-like HIV remission
12 March 2025
CROI 2025: Introduction to this year’s conference
9 March 2025
CROI 2025: Stand Up For Science rally against Trump funding freeze
9 March 2025
CROI 2025: Jay Bhattacharya is proposed to head the US NIH which would further wreck global science
7 March 2025
All early access reports
Current issues
March 2025
February 2025
January 2025
Back issues
Special report
Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer
1 March 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate